Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocarnitine Oxiracetam Injection in Traumatic Brain Injury
CTR20192539Phase 3Completed
- Sponsor
- Nanjing Yoko Pharmaceutical
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levoxiracetam in traumatic brain injury (TBI), sponsored by Nanjing Yoko Pharmaceutical. Started Jul 2020; status: completed.
02
Drugs
levoxiracetam
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on CTR20192539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192539.